Instil Bio, Inc.

NASDAQ (USD): Instil Bio, Inc. (TIL)

Last Price

42.07

Today's Change

+4.58 (12.21%)

Day's Change

35.68 - 42.07

Trading Volume

188,279

Overview

Market Cap

273 Million

Shares Outstanding

6 Million

Avg Volume

250,834

Avg Price (50 Days)

32.41

Avg Price (200 Days)

16.29

PE Ratio

-2.29

EPS

-18.39

Earnings Announcement

11-Nov-2024

Previous Close

37.49

Open

37.41

Day's Range

35.68 - 42.07

Year Range

6.08 - 92.0

Trading Volume

188,534

Price Change Highlight

1 Day Change

12.22%

5 Day Change

-11.95%

1 Month Change

-9.45%

3 Month Change

230.74%

6 Month Change

285.96%

Ytd Change

441.44%

1 Year Change

476.14%

3 Year Change

-88.38%

5 Year Change

-92.04%

10 Year Change

-92.04%

Max Change

-92.04%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment